Percutaneous hepatic perfusion combined with ipilimumab and nivolumab for metastatic uveal melanoma (CHOPIN): a single-centre, open-label, randomised, phase 2 trial

Journal:

The Lancet Oncology

Published:

2026-03-02

DOI:

10.1016/s1470-2045(25)00720-x

Affiliations:

9

Authors:

21

Go to article

Institutions	Authors	Share
Leiden University Medical Center (LUMC), Netherlands	18.333333 18.333333	0.87
Albert Schweitzer Hospital, Netherlands	1.000000	0.05
Erasmus University Medical Center (Erasmus MC), Netherlands	1.000000	0.05
Netherlands Cancer Institute (NKI), Netherlands	0.333333	0.02
University Hospital of Regensburg (UKR), Germany	0.333333	0.02

Interested in Ophthalmology and Optometry?